Advertisement
Canada markets closed
  • S&P/TSX

    21,969.24
    +83.86 (+0.38%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CAD/USD

    0.7317
    -0.0006 (-0.08%)
     
  • CRUDE OIL

    83.65
    +0.08 (+0.10%)
     
  • Bitcoin CAD

    87,296.46
    -846.27 (-0.96%)
     
  • CMC Crypto 200

    1,330.94
    -65.59 (-4.70%)
     
  • GOLD FUTURES

    2,350.60
    +8.10 (+0.35%)
     
  • RUSSELL 2000

    2,002.29
    +21.18 (+1.07%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,927.90
    +316.14 (+2.03%)
     
  • VOLATILITY

    15.02
    -0.35 (-2.28%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

Merck Snags Yet Another Indication for This Drug Combo

Merck Snags Yet Another Indication for This Drug Combo

The company's blockbuster cancer drug Keytruda was approved in Japan to treat patients with certain types of endometrial cancer.